close
close

Is this diabetes stock a good buy?


Is this diabetes stock a good buy?

We recently published a list of The 7 Best Diabetes Stocks to Buy Now. In this article, we take a look at how Abbott Laboratories (NYSE:ABT) compares to other diabetes stocks. According to the WHO, approximately 422 million people worldwide suffer from diabetes, with the majority living in low- and middle-income countries. Diabetes is directly […]